A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2

Diseases and Abnormal Conditions) Heterozygote Genotype European Continental Ancestry Group Molecular Sequence Data 610 Alleles; Australia; Base Sequence; Case-Control Studies; Chromosome Mapping; Confidence Intervals; Europe; European Continental Ancestry Group; Female; Gene Frequency; Genotype; Haplotypes; Heterozygote; Homozygote; Humans; Linkage Disequilibrium; Molecular Sequence Data; Odds Ratio; Ovarian Neoplasms; Polymorphism, Single Nucleotide; Risk Factors; United States; Chromosomes, Human, Pair 9; Genetic Predisposition to Disease; Genome-Wide Association Study; Medicine (all); Genetics Polymorphism, Single Nucleotide Linkage Disequilibrium 618 03 medical and health sciences 0302 clinical medicine Gene Frequency Ovarian cancer 9201 Clinical Health (Organs Risk Factors 616 Genetics Confidence Intervals Odds Ratio Humans Genetic Predisposition to Disease 111203 Cancer Genetics Gene mapping Alleles Risk assessment Ovarian Neoplasms Base Sequence Homozygote Australia Chromosome Mapping United States 3. Good health Europe Haplotypes Case-Control Studies Female CX Chromosomes, Human, Pair 9 Genome-Wide Association Study
DOI: 10.1038/ng.424 Publication Date: 2009-08-02T17:37:21Z
ABSTRACT
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explain less than half the excess familial risk. We performed a genome-wide association study (GWAS) to identify common ovarian cancer susceptibility alleles. We evaluated 507,094 SNPs genotyped in 1,817 cases and 2,353 controls from the UK and approximately 2 million imputed SNPs. We genotyped the 22,790 top ranked SNPs in 4,274 cases and 4,809 controls of European ancestry from Europe, USA and Australia. We identified 12 SNPs at 9p22 associated with disease risk (P < 10(-8)). The most significant SNP (rs3814113; P = 2.5 x 10(-17)) was genotyped in a further 2,670 ovarian cancer cases and 4,668 controls, confirming its association (combined data odds ratio (OR) = 0.82, 95% confidence interval (CI) 0.79-0.86, P(trend) = 5.1 x 10(-19)). The association differs by histological subtype, being strongest for serous ovarian cancers (OR 0.77, 95% CI 0.73-0.81, P(trend) = 4.1 x 10(-21)).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (251)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....